Latest Articles

The role of psychological care in the treatment of gynecological disorders in girls and young women - an interdisciplinary perspective.

This review article explores the psychological dimension of gynecological disorders in girls and young women, emphasizing the need for interdisciplinary approaches in medical care. Gynecological conditions such as endometriosis, polycystic …

MYC: unveiling novel therapeutic avenues for endometriosis.

Catheter-Directed Sclerotherapy Versus Ovarian Cystectomy for Unilateral Ovarian Endometrioma: A Pilot Randomized Controlled Trial.

Background: Ovarian cystectomy is standard treatment for endometrioma but is associated with decreased ovarian reserve. Catheter-directed sclerotherapy (CDS) is an ovary-sparing image-guided alternative; however, supporting evidence comprises retrospective comparative and …

Women's Health Firms Aim for Earlier Endometriosis Diagnoses Through Menstrual Blood, Multiomics - GenomeWeb

Women's Health Firms Aim for Earlier Endometriosis Diagnoses Through Menstrual Blood, Multiomics GenomeWeb

Absci forms advisory board for endometriosis drug program - Investing.com

Absci forms advisory board for endometriosis drug program Investing.com

Local MP Suella Braverman hits out over trans charity role - Meon Valley Times

Local MP Suella Braverman hits out over trans charity role Meon Valley Times

Endometrial epithelial cells with high ALDH activity control uterine development and regeneration.

Adult stem cells are thought to drive the regenerative potential of the endometrium and contribute to the pathogenesis of endometriosis, however, their identity and defining features remain to be characterized. …

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - BioSpace

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis BioSpace

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis - PR Newswire

EndoCyclic Therapeutics Announces FDA Clearance of Investigational New Drug (IND) Application for ENDO-205, a First-in-Class Non-Hormonal Precision Peptide Therapeutic for Endometriosis PR Newswire

For years, Jo was told her pain was "normal". It took over her life. - The Australian Women's Weekly

For years, Jo was told her pain was "normal". It took over her life. The Australian Women's Weekly